Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03343613
Title A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

Advanced Solid Tumor

head and neck squamous cell carcinoma

transitional cell carcinoma

lung non-small cell carcinoma

Therapies

LY3300054 + LY3381916

LY3381916

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | BEL

Facility Status City State Zip Country Details
IU Simon Cancer Center Indianapolis Indiana 46202 United States Details
Sarah Cannon Research Institute SCRI Nashville Tennessee 37203 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
Institut Jules Bordet Brussel 1000 Belgium Details
Universitair Ziekenhuis Antwerpen Edegem 2650 Belgium Details
Universitair Ziekenhuis Gent Gent 9000 Belgium Details
Finsen Institute Copenhagen 2100 Denmark Details
Gustave Roussy Villejuif Cedex 94805 France Details
Azienda Ospedaliera San Gerardo Monza Milano 20052 Italy Details
Azienda Ospedaliera Umberto I Ancona 60100 Italy Details
Hospital Clinico Universitario Virgen de la Victoria Malaga Andalucia 29010 Spain Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field